Viktoria Blumenberg

1.8k total citations
32 papers, 361 citations indexed

About

Viktoria Blumenberg is a scholar working on Oncology, Electrical and Electronic Engineering and Molecular Biology. According to data from OpenAlex, Viktoria Blumenberg has authored 32 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 9 papers in Electrical and Electronic Engineering and 7 papers in Molecular Biology. Recurrent topics in Viktoria Blumenberg's work include CAR-T cell therapy research (29 papers), Integrated Circuits and Semiconductor Failure Analysis (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Viktoria Blumenberg is often cited by papers focused on CAR-T cell therapy research (29 papers), Integrated Circuits and Semiconductor Failure Analysis (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Viktoria Blumenberg collaborates with scholars based in Germany, United States and France. Viktoria Blumenberg's co-authors include Michael von Bergwelt‐Baildon, Kai Rejeski, Veit Bücklein, Marion Subklewe, Christian Schmidt, Wolfgang G. Kunz, Philipp Karschnia, Pere Barba, Gloria Iacoboni and Michael Winkelmann and has published in prestigious journals such as Nature Medicine, Blood and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Viktoria Blumenberg

29 papers receiving 359 citations

Peers

Countries citing papers authored by Viktoria Blumenberg

Since Specialization

Citations

This map shows the geographic impact of Viktoria Blumenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktoria Blumenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktoria Blumenberg more than expected).

Fields of papers citing papers by Viktoria Blumenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktoria Blumenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktoria Blumenberg. The network helps show where Viktoria Blumenberg may publish in the future.

Co-authorship network of co-authors of Viktoria Blumenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Viktoria Blumenberg. A scholar is included among the top collaborators of Viktoria Blumenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktoria Blumenberg. Viktoria Blumenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma 2025 ·HemaSphere ·Sophia Stock, Veit Bücklein, Viktoria Blumenberg, (unknown), (unknown), Alessandra Holzem, David M. Cordas dos Santos, (unknown), (unknown), Lisa Frölich, Sebastian Kobold, Michael von Bergwelt‐Baildon, Kai Rejeski, (unknown)	6
2	Tracking non-relapse mortality after CAR T cell therapy 2024 ·Nature Medicine ·Viktoria Blumenberg, Marcela V. Maus	1
3	Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy 2023 ·Cancer Immunology Research ·Kai Rejeski, David M. Cordas dos Santos, Nathan H. Parker, Veit Bücklein, Michael Winkelmann, (unknown), (unknown), (unknown), Sophie Günther, Philipp Karschnia, Viktoria Blumenberg, (unknown), Wolfgang G. Kunz, Michael von Bergwelt‐Baildon, Michael D. Jain, Sebastian Theurich, Marion Subklewe	20
4	Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy 2023 ·Journal for ImmunoTherapy of Cancer ·Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, (unknown), Veit Bücklein, (unknown), Marcus Unterrainer, Christian Schmidt, (unknown), Peter Bartenstein, Jens Ricke, Michael von Bergwelt‐Baildon, Marion Subklewe, Wolfgang G. Kunz	0
5	Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria 2023 ·Cancer Imaging ·Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, Veit Bücklein, (unknown), Marcus Unterrainer, Christian Schmidt, (unknown), Peter Bartenstein, Jens Ricke, Michael von Bergwelt‐Baildon, Marion Subklewe, Wolfgang G. Kunz	1
6	Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy 2023 ·Annals of Hematology ·Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, (unknown), Veit Bücklein, (unknown), Marcus Unterrainer, Christian Schmidt, (unknown), Peter Bartenstein, Jens Ricke, Michael von Bergwelt‐Baildon, Marion Subklewe, Wolfgang G. Kunz	4
7	Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy 2023 ·Cytotherapy ·Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, (unknown), Veit Bücklein, (unknown), Marcus Unterrainer, Christian Schmidt, (unknown), Peter Bartenstein, Jens Ricke, Michael von Bergwelt‐Baildon, Marion Subklewe, Wolfgang G. Kunz	4
8	Single-Cell Transcriptomic Profiling of T Cells from Blinatumomab-Treated Patients with B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Reveals Circulating CD8 T Cell Subsets Associated with Treatment Response 2023 ·Blood ·Francesco Corrado, (unknown), Tobias Straub, Daniel Nixdorf, Anetta Marcinek, (unknown), (unknown), Christina E. Zielinski, Michael von Bergwelt‐Baildon, Viktoria Blumenberg, Maryam Kazerani, Marion Subklewe, Veit Buecklein	0
9	Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, Veit Bücklein, (unknown), Marcus Unterrainer, Christian Schmidt, (unknown), Peter Bartenstein, Jens Ricke, Michael von Bergwelt‐Baildon, Marion Subklewe, Wolfgang G. Kunz	12
10	Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies 2022 ·Haematologica ·David M. Cordas dos Santos, Kai Rejeski, Michael Winkelmann, Lian Liu, (unknown), Sophie Günther, Veit Bücklein, Viktoria Blumenberg, Christian Schmidt, Wolfgang G. Kunz, Michael von Bergwelt‐Baildon, Sebastian Theurich, Marion Subklewe	24
11	Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment 2022 ·Frontiers in Oncology ·Michael Winkelmann, Veit Bücklein, Viktoria Blumenberg, Kai Rejeski, (unknown), Marcus Unterrainer, Christian Schmidt, (unknown), Peter Bartenstein, Jens Ricke, Michael von Bergwelt‐Baildon, Marion Subklewe, Wolfgang G. Kunz	7
12	Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy 2022 ·Blood Advances ·Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt‐Baildon, Emmanuel Bachy, Pere Barba, Marion Subklewe	36
13	Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment 2022 ·Blood Advances ·(unknown), Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, (unknown), Veit Bücklein, Kai Rejeski, Christian Schmidt, (unknown), Michael von Bergwelt‐Baildon, Jörg‐Christian Tonn, Michael Schmitt, Marion Subklewe, Louisa von Baumgarten	28
14	Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival 2022 ·HemaSphere ·Michael Winkelmann, Kai Rejeski, Viktoria Blumenberg, Veit Bücklein, (unknown), Marcus Unterrainer, Christian Schmidt, (unknown), Peter Bartenstein, Jens Ricke, Michael von Bergwelt‐Baildon, Marion Subklewe, Wolfgang G. Kunz	4
15	High Bacterial Abundances of Dorea and Pediococcus in the Gut Microbiome Linked to Expansion, Immune Checkpoint Expression and Efficacy of CD19-Directed CAR T-Cells in Patients with r/r DLBCL 2021 ·Blood ·Viktoria Blumenberg, (unknown), S. Baumann, Sabine Schmidt, (unknown), Michael Winkelmann, (unknown), Kai Rejeski, Franziska Vettermann, Wolfgang G. Kunz, (unknown), Veit Buecklein, (unknown), Marion Subklewe	5
16	Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell therapy – a case report 2021 ·BMC Infectious Diseases ·Kai Rejeski, Wolfgang G. Kunz, Martina Rudelius, Veit Bücklein, Viktoria Blumenberg, Christian Schmidt, Philipp Karschnia, Florian Schöberl, Konstantin Dimitriadis, Louisa von Baumgarten, Hans‐Joachim Stemmler, Oliver Weigert, Martin Dreyling, Michael von Bergwelt‐Baildon, Marion Subklewe	41
17	Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection 2021 ·HemaSphere ·(unknown), (unknown), Sibylle C. Mellinghoff, Martin Thelen, Alessia Fraccaroli, Viktoria Blumenberg, Philipp Koehler, Wolfgang G. Kunz, Martina Rudelius, (unknown), Marion Subklewe, Hans Schlößer, Johanna Tischer, Oliver A. Cornely, Lars H. Lindner, Michael von Bergwelt‐Baildon	20
18	Antibiotic Therapy and Low Gut Microbiome Diversity Is Associated with Decreased Response and High Toxicity in BCP-ALL and DLBCL Patients after Treatment with CD19. CAR T-Cells 2020 ·Blood ·Viktoria Blumenberg, Maria‐Luisa Schubert, Eli Zamir, Sabine Schmidt, (unknown), (unknown), (unknown), (unknown), Eran Elinav, Christian Schmidt, Veit Buecklein, Carsten Müller‐Tidow, Peter Dreger, (unknown), Michael Schmitt, Marion Subklewe, (unknown)	13
19	Identification of Predictive Markers of Severe and Prolonged Neutropenia after CD19-Specific CAR T-Cell Treatment in Patients with Relapsed/Refractory B-Cell Malignancies 2020 ·Blood ·Kai Rejeski, Carolina Berger, (unknown), Semjon Willier, Viktoria Blumenberg, Veit Buecklein, Christoph Faul, Christian Schmidt, (unknown), Tobias Feuchtinger, Wolfgang Bethge, Francis Ayuk, Marion Subklewe	1
20	Nebenwirkungen von CAR-T-Zellen 2019 ·Kathrin Heinrich, Viktoria Blumenberg, Michael von Bergwelt‐Baildon, Sebastian Kobold	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact